{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:47:40Z","timestamp":1747162060812,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Congenital Heart Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijcchd.2024.100545","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T20:02:41Z","timestamp":1727294561000},"page":"100545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2487-843X","authenticated-orcid":false,"given":"Fabienne","family":"Dirbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Goulouti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Bouchardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magalie","family":"Ladouceur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-291X","authenticated-orcid":false,"given":"Tobias","family":"Rutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ijcchd.2024.100545_bib1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/CIRCULATIONAHA.109.866319","article-title":"Atrial arrhythmias in adults with congenital heart disease","volume":"120","author":"Bouchardy","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcchd.2024.100545_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"ESC Guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcchd.2024.100545_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-016-0088-y","article-title":"Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences","volume":"14","author":"Schein","year":"2016","journal-title":"Thromb J"},{"key":"10.1016\/j.ijcchd.2024.100545_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-12-14","article-title":"Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression","volume":"12","author":"Mearns","year":"2014","journal-title":"Thromb J"},{"issue":"Suppl 1","key":"10.1016\/j.ijcchd.2024.100545_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2004.08.015","article-title":"Hematological management of the cyanotic adult with congenital heart disease","volume":"97","author":"Oechslin","year":"2004","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ijcchd.2024.100545_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/heartjnl-2012-301685","article-title":"Management of adults with cyanotic congenital heart disease","volume":"101","author":"Oechslin","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.ijcchd.2024.100545_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijcard.2016.08.223","article-title":"Thromboprophylaxis for atrial arrhythmias in congenital heart disease: a multicenter study","volume":"223","author":"Khairy","year":"2016","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.ijcchd.2024.100545_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ijcchd.2024.100545_bib9","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ijcchd.2024.100545_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcchd.2024.100545_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2019.09.077","article-title":"Direct oral anticoagulants in adults with congenital heart disease - a single centre study","volume":"300","author":"Pujol","year":"2020","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ijcchd.2024.100545_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/heartjnl-2014-305576","article-title":"Anticoagulation in adults with congenital heart disease: the who, the when and the how?","volume":"101","author":"Jensen","year":"2015","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.ijcchd.2024.100545_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cjca.2014.09.002","volume":"30","author":"Khairy","year":"2014","journal-title":"Can J Cardiol"},{"issue":"43","key":"10.1016\/j.ijcchd.2024.100545_bib14","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1093\/eurheartj\/ehaa844","article-title":"Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients","volume":"41","author":"Freisinger","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcchd.2024.100545_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2019.06.014","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study","volume":"299","author":"Yang","year":"2020","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcchd.2024.100545_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1113-0655","article-title":"Does one dose really fit all? On the monitoring of direct oral anticoagulants: a review of the literature","volume":"40","author":"Moner-Banet","year":"2020","journal-title":"H\u00e4mostaseologie"},{"issue":"9","key":"10.1016\/j.ijcchd.2024.100545_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/jth.12638","article-title":"D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial","volume":"12","author":"Christersson","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ijcchd.2024.100545_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1076029617746506","article-title":"Thrombin generation biomarkers decline with parenteral anticoagulation-an overlooked means of anticoagulation monitoring?","volume":"24","author":"McFarland","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ijcchd.2024.100545_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2019.12.005","article-title":"Rivaroxaban in patients with mechanical heart valves: a pilot study","volume":"186","author":"Roost","year":"2020","journal-title":"Thromb Res"},{"issue":"10","key":"10.1016\/j.ijcchd.2024.100545_bib20","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/jth.13782","article-title":"D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial","volume":"15","author":"Zhang","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.ijcchd.2024.100545_bib21","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ijcchd.2024.100545_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.thromres.2015.06.003","article-title":"Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes","volume":"136","author":"Beyer-Westendorf","year":"2015","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.ijcchd.2024.100545_bib23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjh.18120","article-title":"Managing argatroban in heparin-induced thrombocytopenia: a retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia","volume":"197","author":"Marchetti","year":"2022","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.ijcchd.2024.100545_bib24","first-page":"579","article-title":"[Influence of oral anticoagulant treatment on D-dimers levels]","volume":"59","author":"Ombandza-Moussa","year":"2001","journal-title":"Ann Biol Clin"},{"issue":"3","key":"10.1016\/j.ijcchd.2024.100545_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjcard.2015.10.062","article-title":"Usefulness of direct oral anticoagulants in adult congenital heart disease","volume":"117","author":"Pujol","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcchd.2024.100545_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2020.11.024","article-title":"Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation: a multicenter retrospective cohort study","volume":"327","author":"Kawamatsu","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcchd.2024.100545_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10557-021-07298-5","article-title":"A multisite retrospective review of direct oral anticoagulants compared to warfarin in adult fontan patients","volume":"37","author":"Kazerouninia","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"10.1016\/j.ijcchd.2024.100545_bib28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.21037\/cdt-20-631","article-title":"Anticoagulation management in adult patients with congenital heart disease: a narrative review","volume":"11","author":"Sinning","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"issue":"15","key":"10.1016\/j.ijcchd.2024.100545_bib29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/hrt.2010.196147","article-title":"Cerebrovascular accidents in adult patients with congenital heart disease","volume":"96","author":"Hoffmann","year":"2010","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcchd.2024.100545_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003071","article-title":"Ischemic stroke in children and young adults with congenital heart disease","volume":"5","author":"Mandalenakis","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.ijcchd.2024.100545_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/heartjnl-2017-311620","article-title":"Factors associated with coronary artery disease and stroke in adults with congenital heart disease","volume":"104","author":"Bokma","year":"2018","journal-title":"Heart"},{"issue":"25","key":"10.1016\/j.ijcchd.2024.100545_bib32","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/CIRCULATIONAHA.115.011241","article-title":"Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors","volume":"132","author":"Lanz","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcchd.2024.100545_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000985","article-title":"Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe","volume":"6","author":"Yang","year":"2019","journal-title":"Open Heart"}],"container-title":["International Journal of Cardiology Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668524000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668524000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T01:55:07Z","timestamp":1732586107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666668524000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"alternative-id":["S2666668524000545"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcchd.2024.100545","relation":{},"ISSN":["2666-6685"],"issn-type":[{"type":"print","value":"2666-6685"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Congenital Heart Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcchd.2024.100545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100545"}}